Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Launched by SANGUINE BIOSCIENCES · Nov 22, 2022

Keywords

ClinConnect Summary

This clinical trial is focused on collecting and preserving biological samples (like blood or tissue) and medical information to help researchers find new treatments and ways to prevent various health conditions. These conditions include a wide range of diseases, such as Alzheimer's, cancer, diabetes, and many others. By gathering these samples, the study aims to support important biomedical research led by qualified investigators.

To participate in this trial, you need to be between 18 and 85 years old and have a medical record that confirms your diagnosis of a specific condition, or you can share your condition details through self-reporting. If you qualify, you will sign a consent form, which explains the study and allows for the use of your medical information. Participants can expect to provide a sample and answer questions about their health, all while contributing to research that could lead to better treatments in the future. It's an opportunity to help advance medical knowledge for many serious health issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Persons 18 to 85 years of age at the date of informed consent.
• • If presenting with a history of a specific condition, the diagnosis is confirmable in the medical record or may be confirmed using other forms of verification including self-reporting.
• • Understands the procedures and requirements of the study by providing written informed consent (or verbal assent if a legally authorized representative will sign the ICF), including consent for authorization for protected health information disclosure.
• Exclusion Criteria:
• • Persons younger than 18 years of age or older than 85 years of age at the date of informed consent.
• • Receipt of blood products 30 days before the study blood draw.
• • Receipt of an investigational (unapproved) drug 30 days before the study blood draw.
• • A confirmable diagnosis of any medical condition that would increase potential phlebotomy risks.
• • Has donated a unit of blood within the last 2 months at the date of informed consent.